Tennessee House Bill HB0667

Tennessee 2023-2024 Regular Session

• Introduced: 1/26/23
• Refer: 2/1/23
• Refer: 3/14/23
• Refer: 3/22/23
• Chaptered: 5/3/23
• Passed: 5/3/23

Caption

AN ACT to amend Tennessee Code Annotated, Title 56; Title 63 and Title 68, relative to a prescription drug donation repository program.

Impact

If enacted, HB 0667 would provide a structured framework for handling donated prescription drugs and establish liability protections for those involved in the donation and dispensing process, with exceptions pertaining to gross negligence or misconduct. This measure is expected to improve healthcare access for low-income patients by allowing repositories to provide essential medications without charge, aside from a nominal handling fee. Additionally, it aims to reduce waste in the pharmaceutical sector by encouraging the use of surplus medications that would otherwise be discarded.

Summary

House Bill 0667, known as the 'Kevin Clauson Drug Donation Act', aims to amend Tennessee Code Annotated to establish a prescription drug donation repository program. This program facilitates the donation of unused prescription drugs from various entities including pharmacies, medical facilities, and manufacturers to be dispensed to eligible individuals, specifically targeting those who are indigent, uninsured, or underinsured. The bill aims to enhance access to necessary medications for vulnerable populations, thereby promoting public health and assisting those who cannot afford their prescriptions.

Sentiment

The sentiment surrounding HB 0667 appears largely supportive, emphasizing the importance of enhancing healthcare access for marginalized populations. Advocates argue that this legislation will significantly benefit low-income communities by ensuring they have access to crucial medications. However, there may also be concerns regarding the logistical aspects of implementing such a program, especially ensuring drug safety and managing the inventory of donated pharmaceuticals.

Contention

Notable points of contention include ensuring the safety of donated medications and the viability of the repository program. Critics may question how effectively the program will be implemented and monitored to avoid potential misuse, and there may be discussions surrounding the implications for pharmaceutical manufacturers regarding liability and drug handling protocols. Ensuring compliance with safety regulations while maximizing the donations' utility will be essential to the success of the program.